PThe "Epiomic Epidemiology Series: Onychomycosis Forecast In 22 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.
This report provides the current prevalent population for Onychomycosis across 22 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Sweden, Denmark, Finland, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors and prevention, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from our analysis team, patient groups divided by disease classification, aetiology, main symptoms and co-morbidities have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Onychomycosis include:
Reasons to buy
Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/research/75ffjj/onychomycosis?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005574/en/